SEGATORI VALERIA INÉS; MAGALI GRETEL FERREYRA; SELENE ROJO; AYLEN CAMILA NOGUEIRA; JEREMÍAS OMAR CASTILLO; GULINO, CYNTHIA ANABELLA; GABRI, MARIANO ROLANDO

Mimicry of Tumour-Associated Carbohydrates: Is It a Promising Option for Cancer Treatment?

Immuno; Lugar: Basel; Año: 2023 vol. 3 p. 122 - 147

CUELLO, HECTOR ADRIÁN; MAGALI GRETEL FERREYRA; GULINO, CYNTHIA A.; GOMEZ TOLEDO, A; SEGATORI VALERIA INÉS; GABRI MARIANO R

Terminally sialylated and fucosylated complex N-glycans are involved in the malignant behavior of high-grade glioma

Oncotarget; Año: 2020 vol. 11 p. 4822 - 4835

ALBERTÓ, MARINA; CUELLO, HECTOR ADRIÁN; GULINO, CYNTHIA ANABELLA; PIFANO, MARINA; BELGOROSKY, DENISE; GABRI, MARIANO ROLANDO; EIJÁN, ANA MARÍA; SEGATORI, VALERIA INÉS

Expression of bladder cancer-associated glycans in murine tumor cell lines

Oncology Letters; Año: 2019 vol. 17 p. 3141 - 3150

PALOMO AG; MEDINILLA AL; SEGATORI VALERIA INÉS; BARROSO MDC; BLANCO R; GABRI MARIANO R; PEREZ AC; MONZÓN KL

Synergistic potentiation of the anti-metastatic effect of anti EGFR mAb by its combination with immunotherapies targeting the ganglioside NGcGM3

Oncotarget; Lugar: Nueva York; Año: 2018 vol. 8 p. 24069 - 24080

SEGATORI, VALERIA I.; CUELLO, HÉCTOR A.; GULINO, CYNTHIA A.; ALBERTÓ, MARINA; VENIER, CECILIA; GUTHMANN, MARCELO D.; DEMARCO, IGNACIO A.; ALONSO, DANIEL F.; GABRI, MARIANO R.

Antibody-dependent cell-mediated cytotoxicity induced by active immunotherapy based on racotumomab in non-small cell lung cancer patients

CANCER IMMUNOLOGY IMMUNOTHERAPY; Año: 2018 vol. 67 p. 1285 - 1296

CUELLO, HECTOR ADRIÁN; SEGATORI VALERIA INÉS; ALBERTÓ MARINA; GULLINO CYNTHIA; ASCHERO ROSARIO; CAMARERO, SANDRA; MUTTI LG; MADAUS KEVIN; ALONSO DANIEL F; LUBIENICKI FABIANA; GABRI MARIANO R

Aberrant O-glycosylation modulates aggressiveness in neuroblastoma

Oncotarget; Lugar: Nueva York; Año: 2018 vol. 9 p. 34176 - 34188

GABRI MARIANO R; CACCIAVILLANO W; GUILLERMO CHANTADA; ALONSO DANIEL F

Racotumomab for treating lung cancer and pediatric refractory malignancies

EXPERT OPINION ON BIOLOGICAL THERAPY; Lugar: London; Año: 2016 vol. 16 p. 573 - 578

HÉCTOR CUELLO; SEGATORI VALERIA INÉS; ALBERTÓ MARINA; PESCE A; ALONSO DANIEL F; GABRI MARIANO R

Comparability of Antibody-Mediated Cell Killing Activity Between a Proposed Biosimilar RTXM83 and the Originator Rituximab

BIODRUGS; Año: 2016 vol. 30 p. 225 - 231

PALOMO AG; SANTANA RB; PEREZ XE; SANATANA DB; GABRI MARIANO R; KALET LM; CARR A

Frequent co-expression of EGFR and NeuGcGM3 ganglioside in cancer: it's potential therapeutic implications

CLINICAL & EXPERIMENTAL METASTASIS; Lugar: Berlin; Año: 2016 vol. 33 p. 717 - 725

LAURENT, VIVIANA E.; TORBIDONI, ANA VANESA; SAMPOR, CLAUDIA; OTTAVIANI, DANIELA; VAZQUEZ, VALERIA; GABRI, MARIANO R.; GARCIA DE DAVILA, MARIA TERESA; RAMIREZ-ORTIZ, MARCO A.; ALONSO, CRISTINA NOEMI; ROSSI, JORGE; ALONSO, DANIEL F.; CHANTADA, GUILLERMO L.

Minimal Disseminated Disease in Nonmetastatic Retinoblastoma With High-Risk Pathologic Features and Association With Disease-Free Survival

JAMA Ophthalmology; Año: 2016 vol. 134

CACCIAVILLANO W; SAMPOR C; VENIER C; GABRI MR; DAVILA, MARÍA; L. GALLUZZO; GUTHMANN MD; FAINBOIM L; ALONSO DF; GUILLERMO CHANTADA

A Phase I Study of the Anti-Idiotype Vaccine Racotumomab in Neuroblastoma and Other Pediatric Refractory Malignancies

PEDIATRIC BLOOD & CANCER; Lugar: New York; Año: 2015 vol. 62 p. 2120 - 2124

TORVIDONI AV; VIVIANA E. LAURENT; CLAUDIA SAMPOR; OTTAVIANI D; VALERIA VAZQUEZ; GABRI MR; JORGE ROSSI; DAVILA, MARÍA; ALONSO C; ALONSO DF; GUILLERMO CHANTADA

Association of Cone-Red Homeobox Transcription Factor Messenger RNA With Pediatric Metastatic Retinoblastoma

JAMA Ophthalmology; Año: 2015 vol. 133 p. 805 - 812

VIVIANA E. LAURENT; CLAUDIA SAMPOR; VERÓNICA SALERNOU; JORGE ROSSI; GABRI MARIANO R; SILVIA EANDI-EBERLE; DAVILA, MARÍA; DANIEL F ALONSO; GUILLERMO CHANTADA

Detection of minimally disseminated disease in the cerebrospinal fluid of children with high-risk retinoblastoma by reverse transcriptase-polymerase chain reaction for GD2 synthase mRNA

EUROPEAN JOURNAL OF CANCER; Lugar: Amsterdam; Año: 2013

A.M. VAZQUEZ; HERNANDEZ AM; A. MACIAS; ENRIQUE MONTERO; D. E. GOMEZ; ALONSO DANIEL F; GABRI MARIANO R; GOMEZ RE

Racotumomab: an anti-idiotype vaccine related to N-glycolyl-containing gangliosides - preclinical and clinical data

Frontiers in Oncology; Año: 2012 vol. 2 p. 150 - 160

VALERIA I. SEGATORI; A.M. VAZQUEZ; D. E. GOMEZ; GABRI MARIANO R; ALONSO DANIEL F

Preclinical evaluation of racotumomab, an anti-idiotype monoclonal antibody to N-glycolyl-containing gangliosides, with or without chemotherapy in a mouse model of non-small cell lung cancer

Frontiers in Oncology; Año: 2012 vol. 2 p. 160 - 170

VALERIA I. SEGATORI; LAURA L. OTERO; LUIS E. FERNANDEZ; DANIEL E GOMEZ; DANIEL F ALONSO; MARIANO R. GABRI

Antitumor Protection by NGcGM3/VSSP Vaccine Against Transfected B16 Mouse Melanona Cells Overexpressing N-Glycolylated Gangliosides

IN VIVO; Lugar: Atenas; Año: 2012 vol. 26 p. 609 - 617

OTERO LL; ALONSO DF; CASTRO M; CINAT G; GABRI M; GOMEZ DE

Tissue factor as a novel marker for detection of circulating cancer cells

BIOMARKERS; Lugar: Londres; Año: 2011 vol. 16 p. 58 - 64

SCURSONI AM; L. GALLUZZO; CAMARERO S; LOPEZ J; LUBIENICKI F; SAMPOR C; VALERIA I. SEGATORI; GABRI MARIANO R; ALONSO DANIEL F; GUILLERMO CHANTADA; DAVILA, MARÍA

Detection of N-Glycolyl GM3 Ganglioside in Neuroectodermal Tumors by Immunohistochemistry: An Attractive Vaccine Target for Aggressive Pediatric Cancer

CLINICAL AND DEVELOPMENTAL IMMUNOLOGY; Lugar: New York; Año: 2011 vol. 2011 p. 245181 - 245181

SCURSONI AM; L. GALLUZZO; CAMARERO S; LOPEZ J; LUBIENICKI F; SAMPOR C; VALERIA I. SEGATORI; GABRI MARIANO R; ALONSO DANIEL F; GUILLERMO CHANTADA; DAVILA, MARÍA

Detection of N-Glycolyl GM3 Ganglioside in Neuroectodermal Tumors by Immunohistochemistry: An Attractive Vaccine Target for Aggressive Pediatric Cancer

CLINICAL & DEVELOPMENTAL IMMUNOLOGY; Lugar: New York; Año: 2011 vol. 2011 p. 245181 - 245181

FERNANDEZ LE; GABRI MR; GUTHMANN MD; GOMEZ RE; GOLD S; FAINBOIM L; GOMEZ DE; ALONSO DF

NGcGM3 ganglioside: a privileged target for cancer vaccines

CLINICAL & DEVELOPMENTAL IMMUNOLOGY; Lugar: New York; Año: 2010 vol. 2010 p. 814397 - 814397

VIVIANA E. LAURENT; LAURA L. OTERO; VALERIA VAZQUEZ; SANDRA CAMARERO; MARIANO R GABRI; MARÍA LABRAGA; MARÍA TERESA G. DE DÁVILA; GUILLERMO CHANTADA; DANIEL F. ALONSO

Optimization of molecular detection of GD2 synthase mRNA in retinoblastoma

MOLECULAR MEDICINE REPORTS; Lugar: Atenas; Año: 2010 vol. 3 p. 253 - 259

FUENTES D; AVELLANET J; GARCIA A; IGLESIAS N; GABRI MR; ALONSO DF; VAZQUEZ AM; PEREZ R; MONTERO E

Combined therapeutic effect of a monoclonal anti-idiotype tumor vaccine against NeuGc-containing gangliosides with chemotherapy in a breast carcinoma model

BREAST CANCER RESEARCH AND TREATMENT; Año: 2010 vol. 120 p. 379 - 389

ALEJANDRA M. SCURSONI; LAURA GALLUZZO; SANDRA CAMARERO; NORMA POZZO; MARIANO R. GABRI; CRISTINA MATEO DE ACOSTA; ANA MARÍA VÁZQUEZ; DANIEL F. ALONSO; MARÍA TERESA G. DE DÁVILA

Detection and Characterization of N-Glycolylated Gangliosides in Wilms Tumor by Immunohistochemistry

PEDIATRIC AND DEVELOPMENTAL PATHOLOGY; Año: 2010 vol. 13 p. 18 - 23

MAYREL LABRADA; MARILYN CLAVELL; YANÍN BEBELAGUA; JOEL DE LEÓN; DANIEL F. ALONSO; MARIANO R. GABRI; ROBERTO C. VELOSO; VICENTE VERÉZ; LUIS E. FERNANDEZ

Direct validation of NGcGM3 ganglioside as a new target for cancer immunotherapy

EXPERT OPINION ON BIOLOGICAL THERAPY; Año: 2010 vol. 10 p. 153 - 162

FERNANDEZ LE; GABRI MR; GUTHMANN MD; GOMEZ RE; GOLD S; FAINBOIM L; GOMEZ DE; ALONSO DF

NGcGM3 ganglioside: a privileged target for cancer vaccines

CLINICAL AND DEVELOPMENTAL IMMUNOLOGY; Lugar: New York; Año: 2010 vol. 2010 p. 814397 - 814397

VALERIA VAZQUEZ; LAURA L. OTERO; VIVIANA E. LAURENT; MARIANO R. GABRI; DANIEL E. GOMEZ; DANIEL F. ALONSO

Detección molecular de enfermedad mínima residual en melanoma y otros tumores sólidos

MEDICINA-BUENOS AIRES; Lugar: Buenos Aires; Año: 2009 vol. 69 p. 181 - 190

MARIANO R. GABRI; LAURA L. OTERO; DANIEL E. GÓMEZ; DANIEL F. ALONSO

Exogenous incorporation of neuGc-rich mucin augments N-glycolyl sialic acid content and promotes malignant phenotype in mouse tumor cell lines

JOURNAL OF EXPERIMENTAL AND CLINICAL CANCER RESEARCH; Año: 2009 vol. 28 p. 1 - 8

VALERIA VAZQUEZ; LAURA L. OTERO; VIVIANA E. LAURENT; MARIANO R. GABRI; DANIEL E. GOMEZ; DANIEL F. ALONSO

Detección molecular de enfermedad mínima residual en melanoma y otros tumores sólidos

MEDICINA (BUENOS AIRES); Lugar: Buenos Aires; Año: 2009 vol. 69 p. 181 - 190

MARIANO R. GABRI; LAURA L. OTERO; DANIEL E. GÓMEZ; DANIEL F. ALONSO

Exogenous incorporation of neuGc-rich mucin augments N-glycolyl sialic acid content and promotes malignant phenotype in mouse tumor cell lines

JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH; Año: 2009 vol. 28 p. 1 - 8

MARIANO R GABRI; VALERIA VAZQUEZ; SANTIAGO GIRÓN; MÓNICA A. CASTRO; GABRIELA CINAT; ROBERTO E. GOMEZ; FEDERICO M. SANTORO; DANIEL E. GOMEZ; DANIEL F. ALONSO

Molecular detection of circulating tyrosinase mRNA: optimization in a preclinical xenograft mouse melanoma model and further evaluation in samples from advanced melanoma patients

INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE; Lugar: Grecia; Año: 2008 vol. 21 p. 555 - 559

NENINGER E; DIAZ RM; DE LA TORRE A; RIVES R; DIAZ A; SAUREZ G; GABRI MR; ALONSO DF; WILKINSON B; ALFONSO AM; COMBET T; PEREZ R; VAZQUEZ AM

Active Immunotherapy with 1E10 Anti-Idiotype Vaccine in Patients with Small Cell Lung Cancer: Report of a Phase I Trial

CANCER BIOLOGY & THERAPY; Año: 2007 vol. 6 p. 145 - 150

S. ALFONSO; R.M. DÍAZ; A. DE LA TORRE; E. SANTIESTEBAN; F. AGUIRRE; K. PEREZ; J.L. RODRIGUEZ; M.C. BARROSO; A.M. HERNÁNDEZ; D. TOLEDO; M.R. GABRI; D.F. ALONSO; C. VIADA; R.E. GOMEZ; E. PESTANA; A.M. VAZQUEZ; R. PEREZ; A. MACIAS

1E10 anti-idiotype vaccine in non-small cell lung cancer: experience in stage IIIb/IV patients

CANCER BIOLOGY & THERAPY; Año: 2007 vol. 6 p. 1 - 6

TIMO SCHINKÖTHE; SVENJA HAEGER; MARIANO R. GABRI

Practical Guidelines for Diagnostic Use of In Vitro Chemosensitivity Tests

ANTICANCER RESEARCH; Año: 2007 vol. 27 p. 1365 - 1367

MARIANO R. GABRI; ZAIMA MAZORRA; GISELLE V. RIPOLL1; CIRCE MESA; LUIS E. FERNANDEZ; DANIEL E. GOMEZ; DANIEL F. ALONSO

Complete antitumor protection by perioperative immunization with GM3/VSSP vaccine in a preclinical mouse melanoma model

CLINICAL CANCER RESEARCH; Año: 2006 vol. 12 p. 7092 - 7098

GUTHMANN MD; BITTON RJ; CARNERO AJ; GABRI MR; CINAT G; KOLIREN L; LEWI D; FERNANDEZ LE; ALONSO DF; GOMEZ DE; FAINBOIM L

Active specific immunotherapy of melanoma with a GM3 ganglioside-based vaccine: a report on safety and immunogenicity

JOURNAL OF IMMUNOTHERAPY; Lugar: Hagerstown, Md; Año: 2004 vol. 27 p. 442 - 451

CARR A; RODRIGUEZ E; ARANGO MDEL C; CAMACHO R; OSORIO M; GABRI M; CARRILLO G; VALDES Z; BEBELAGUA Y; PEREZ R; FERNANDEZ LE

Immunotherapy of advanced breast cancer with a heterophilic ganglioside (NeuGcGM3) cancer vaccine.

JOURNAL OF CLINICAL ONCOLOGY; Año: 2003 vol. 21 p. 1015 - 1021

ALONSO DANIEL F; FARINA HERNÁN G; TEJERA AGUEDA M; GABRI MARIANO R; GÓMEZ DANIEL

Hacia nuevas formas de tratamiento del cáncer

Ciencia Hoy; Lugar: Buenos Aires; Año: 2003 vol. 13 p. 48 - 55

GABRI MR; RIPOLL GV; ALONSO DF; GOMEZ DE

Role of cell surface GM3 ganglioside and sialic acid in the antitumor activity of a GM3-based vaccine in the murine B16 melanoma model.

JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY; Año: 2002 vol. 128 p. 669 - 677

BITTON RJ; GUTHMANN MD; GABRI MR; CARNERO AJ; ALONSO DF; FAINBOIM L; GOMEZ DE

Cancer vaccines: an update with special focus on ganglioside antigens.

ONCOLOGY REPORTS; Año: 2002 vol. 9 p. 267 - 276

VAZQUEZ AM; GABRI MR; HERNANDEZ AM; ALONSO DF; BEAUSOLEIL I; GOMEZ DE; PEREZ R

Antitumor properties of an anti-idiotypic monoclonal antibody in relation to N-glycolyl-containing gangliosides.

ONCOLOGY REPORTS; Año: 2000 vol. 7 p. 751 - 756

GABRI MR; MENNA PL; SCURSONI AM; GOMEZ DE; ALONSO DF

Role of tumor-derived granulocyte-macrophage colony-stimulating factor in mice bearing a highly invasive and metastatic mammary carcinoma.

PATHOBIOLOGY; Año: 1999 vol. 67 p. 180 - 185

DANIEL F. ALONSO; MARIANO R. GABRI; MARCELO D. GUTHMANN; LEONARDO FAINBOIM

A novel hydrophobized GM3 ganglioside/Neisseria meningitidis outer-membrane-protein complex vaccine induces tumor protection in B16 murine melanoma.

INTERNATIONAL JOURNAL OF ONCOLOGY; Año: 1999 vol. 15 p. 59 - 66

ALONSO DF; FARINA HG; SKILTON G; GABRI MR; DE LORENZO MS; GOMEZ DE

Reduction of mouse mammary tumor formation and metastasis by lovastatin, an inhibitor of the mevalonate pathway of cholesterol synthesis.

BREAST CANCER RESEARCH AND TREATMENT; Año: 1998 vol. 50 p. 83 - 93